Search tips Search criteria    Cancer Genet. Author manuscript;
available in PMC 2012 July 1. Published in final edited form as:
PMCID: PMC3164520 Promiscuous Partnerships in Ewing’s Sarcoma
Savita Sankar1 and Stephen L. Lessnick1,2,3* 1Department of
Oncological Sciences, University of Utah School of Medicine,
Salt Lake City, UT, USA 84112. 2Center for Children’s Cancer
Research at Huntsman Cancer Institute, University of Utah, Salt
Lake City, UT, USA 84112. 3Division of Pediatric
Hematology/Oncology, University of Utah School of Medicine, Salt
Lake City, UT. *Address correspondence to: Stephen L. Lessnick,
M.D., Ph.D., Huntsman Cancer Institute, 2000 Circle of Hope,
Room 4242, Salt Lake City, UT 84112, Tel: 801-585-9268, Fax:
801-585-5357, stephen.lessnick/at/ Ewing’s sarcoma is a highly
aggressive bone and soft tissue tumor of children and young
adults. At the molecular genetic level Ewing’s sarcoma is
characterized by a balanced reciprocal translocation,
t(11;22)(q24;q12), which encodes an oncogenic fusion